SSA
ABMD

Schonfeld Strategic Advisors’s Abiomed Inc ABMD Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,300
Closed -$3.27M – 3267
2022
Q3 		$3.27M Buy
+13,300
New +$3.59M 0.03% 685
2021
Q2 		– Sell
-4,912
Closed -$1.57M – 2471
2021
Q1 		$1.57M Buy
+4,912
New +$1.57M 0.02% 737
2020
Q1 		– Sell
-1,473
Closed -$251K – 1639
2019
Q4 		$251K Buy
+1,473
New +$273K 0.01% 1064
2017
Q1 		– Sell
-18,230
Closed -$2.06M – 776
2016
Q4 		$2.06M Buy
+18,230
New +$2.11M 0.27% 109

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Schonfeld Strategic Advisors's ABMD Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 13,300 shares — an estimated $3.27M sold.

Schonfeld Strategic Advisors first reported a position in ABMD in Q4 2016 and held it in 4 quarters. The position peaked at $3.27M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 13,300 Abiomed Inc shares in Q4 2022, an estimated $3.27M.
  • Schonfeld Strategic Advisors first reported a position in Abiomed Inc in Q4 2016 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's Abiomed Inc position peaked at $3.27M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.